Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Horizons ETFs Management (Canada) Inc - BetaPro S&P 500 VIX Short-Term Futures Daily Inverse ETF Class A BTTPF



GREY:BTTPF - Post by User

Horizons ETFs Management (Canada) Inc - BetaPro S&P 500 VIX Short-Term Futures Daily Inverse ETF Class A > Pharma and Bio tech runaway train
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Post by SAGE1on Sep 27, 2015 5:28pm
104 Views
Post# 24139498

Pharma and Bio tech runaway train

Pharma and Bio tech runaway trainThis is ludicrous. If someone netted 30K income for 25 years they could not pay for 1 year treatment.

https://www.stockhouse.com/news/newswire/2015/09/25/u-s-drug-company-challenges-ottawa-s-ability-to-control-patent-drug-prices
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities